| ¿µ¹® | cardiovascular system | ÇÑ±Û | ½ÉÀåÇ÷°ü°è |
|---|---|---|---|
| ¼³¸í | ½ÅüÀÇ Ç÷¾×¼øÈ¯À» ´ã´çÇÏ´Â ±â°ü. Áï ½ÉÀå°ú Ç÷°üÀ» ÅëÄªÇØ¼ À̸£´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | lead poisoning, saturinism | ÇÑ±Û | ³³Áßµ¶ |
|---|---|---|---|
| ¼³¸í | ¿ëÇØ¼º ³³À» ÈíÀÔÇϰųª »ïÅ´À¸·Î½á À¯¹ßµÇ´Â Á÷¾÷º´. ±Þ¼º°ú ¸¸¼ºÀÌ ÀÖÀ¸¸ç ´ë·®À¸·Î Èí¼öÇÏ¿© ±Þ¼º À§Àå¿° Áõ»óÀ» ³ªÅ¸³»´Â ±Þ¼º Áßµ¶Àº ¿ÀÈ÷·Á µå¹°°í, ±Ø¼Ò·®(1ÀÏ 1mg ÀÌÇÏ)ÀÇ ³³À» Àå±â°£ Áö¼ÓÀûÀ¸·Î ¼·ÃëÇÔÀ¸·Î½á »ý±â´Â ¸¸¼ºÀÌ ´õ ½É°¢ÇÏ´Ù. ³³Á¦·Ã¾÷-ȰÆÇÀμâ¾÷-µµÀå¾÷-³³À¯¸®Á¦Á¶¾÷-ÃàÀüÁöÁ¦Á¶¾÷ µî ³³ ¶Ç´Â ³³À» ÇÔÀ¯ÇÑ ¹°ÁúÀ» ´Ù·ç´Â »ç¶÷, ¶Ç °ú°Å¿¡´Â ¿¬¹éÀ» »ç¿ëÇÑ ºÐ¿¡ ÀÇÇÑ ÈÀåµ¶ÀÌ ¿©¼º¿¡°Ô ³ªÅ¸³ª ¹®Á¦°¡ µÇ¾úÀ¸³ª, ¿À´Ã³¯¿¡´Â °¡¼Ö¸°¿¡ È¥ÇÕµÈ ¾ÈƼ³ìÁ¦ÀÎ »ç¿¡Æ¿³³À¸·Î ÀÎÇÑ Áßµ¶ÀÌ ÁÖ¸ñµÇ°í ÀÖ´Ù. »ç¿¡Æ¿³³ Áßµ¶ÀÇ Áõ»óÀº ¿©·¯ °¡ÁöÀε¥, ºóÇ÷À̳ª ¶³¸®´Â Áõ»óÀÌ ºñ±³Àû Ãʱ⿡ ³ªÅ¸³ª°í ³³¼±(ÀÕ¸ö¿¡ ³³ÀÌ Ä§ÂøÇÏ¿© ûȸ¹é»öÀ¸·Î Âø»öµÈ´Ù)À̳ª ¹ßÀÛÀû º¹ÅëÀÌ Æ¯Â¡ÀÌ´Ù. ÀϹÝÀûÀ¸·Î ³³ÀÇ Áõ±â³ª °¡·ç°¡ ±âµµ¸¦ ÅëÇØ ü³»·Î µé¾î°¡´Â °æ¿ì°¡ µµ·á-¾È·á¿¡ µé¾î ÀÖ´Â ³³ÀÌ ÇǺγª ¼ÒȰüÀ» ÅëÇØ ħÅõÇÏ´Â Áõ·Êº¸´Ù Áõ»óÀÌ ½ÉÇÏ´Ù. |
||
| ¿µ¹® | food poisoning | ÇÑ±Û | ½ÄÁßµ¶ |
|---|---|---|---|
| ¼³¸í | À¯Çع°Áú¿¡ ¿À¿°µÈ À½½Ä¹°À» ¸ÔÀ½À¸·Î½á ÀϾ´Â ÀϱºÀÇ ±Þ¼ºÁúȯÀ̸ç, ÁÖ·Î ¹ß¿-±¸¿ªÁú-±¸Åä-¼³»ç-º¹Åë µîÀÇ Áõ¼¼°¡ ³ªÅ¸³´Ù. ÀÔÀ» ÅëÇÑ Àü¿°º´À̳ª ±â»ýÃæº´ µîÀº ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾Ê´Â´Ù. ½ÄÁßµ¶À» ¿øÀι°Áú¿¡ µû¶ó ºÐ·ùÇÏ¸é ¼¼±Õ¼º ½ÄÁßµ¶, ÈÇмº ½ÄÁßµ¶, ÀÚ¿¬µ¶ ½ÄÁßµ¶, ¹Ì»ý¹° µ¶¼º´ë»ç¹°Áú¿¡ ÀÇÇÑ ½ÄÁßµ¶À¸·Î ±¸ºÐÇÒ ¼ö ÀÖ´Ù. °¢ ºÎ·ù¿¡ ¼ÓÇÏ´Â µ¶¼º¹°ÁúÀº ±× Á¾·ù°¡ ¸Å¿ì ¸¹À¸¸ç, µ¶¼º¹°ÁúÀº ´çÀå °Ç°À» ÇØÄ¥¸¸ÇÑ ¾çÀÌ ¾Æ´Ï¶ó ÇÏ´õ¶óµµ ¸¹Àº ½Äǰ Áß¿¡ ³Î¸® ºÐÆ÷µÇ¾î ÀÖ¾î¼ ¸¸¼ºÁßµ¶-¹ß¾Ï¼º-µ¹¿¬º¯ÀÌ À¯¹ß¼º-±âÇüÀ¯¹ß¼º-¾Ë·¹¸£±â¼º ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ¿øÀÎÀÌ µÉ ¼öµµ ÀÖ´Ù. ½ÄÁßµ¶ÀÇ ´ëºÎºÐÀº ¼¼±Õ¿¡ ÀÇÇÏ¿© »ý±â´Â ¼¼±Õ¼º ½ÄÁßµ¶À¸·Î¼, ¿©±â¿¡´Â »ì¸ð³Ú¶ó-Àåºñºê¸®¿À-À£Ä¡±Õ-º´¿ø´ëÀå±Õ¿¡ ÀÇÇÑ °¨¿°Çü ½ÄÁßµ¶°ú Æ÷µµ¾Ë±Õ, º¸Å縮´©½º±ÕÀÌ »ý¼ºÇÑ µ¶¼Ò¿¡ ÀÇÇÑ µ¶¼ÒÇü ½ÄÁßµ¶ÀÌ ÀÖ´Ù. °¨¿°Çü ½ÄÁßµ¶Àº »ì¾Æ ÀÖ´Â À¯Çؼ¼±ÕÀ» ´Ù·®À¸·Î ¸ÔÀ½À¸·Î½á ÀϾ´Â °ÍÀ̹ǷΠ½ÄǰÀ» °¡¿Çؼ ¸ÔÀ¸¸é ¼¼±ÕÀº »ç¸êÇØ ¹ö¸®±â ¶§¹®¿¡ Áßµ¶µÇ´Â ÀÏÀÌ ¾ø´Ù. ±×·¯³ª µ¶¼ÒÇü ½ÄÁßµ¶Àº ¼¼±ÕÀº Á׾ µ¶¼Ò´Â ±×´ë·Î ³²¾Æ ÀÖÀ¸¹Ç·Î À½½Ä¹°À» °¡¿Çصµ ³²Àº µ¶¼Ò°¡ Áßµ¶À» ÀÏÀ¸Å°´Â °æ¿ìÀÌ´Ù. ÈÇмº ½ÄÁßµ¶Àº ÈÇй°Áú¿¡ ÀÇÇÑ °ÍÀ¸·Î¼ ±Ù·¡¿¡ µé¾î¿Í ÈÇаø¾÷ÀÇ ¹ß´Þ·Î ÈÇÐÀû ÇÕ¼ºÇ°ÀÇ ´ë·®»ý»êÀÌ °¡´ÉÇØÁö°í À̵éÀÌ ½Äǰ°ø¾÷À̳ª ³ó¾÷ºÐ¾ß¿¡ ´Ù·®À¸·Î »ç¿ëµÇ¸é¼ ½É°¢ÇÑ ¹®Á¦·Î µîÀåÇÏ¿´´Ù. ƯÈ÷ ½Äǰ°¡°ø°úÁ¤ Áß¿¡ »ç¿ëÇÑ ºÒ¹ý½Äǰ÷°¡¹°, ÀÜ·ù³ó¾à-»ê¾÷Æó¼ö¿¡ ÀÇÇÑ ½ÄǰÀÇ Á߱ݼӿÀ¿°, ¶Ç´Â ½Äǰ°ú °ü·ÃÀÌ ÀÖ´Â °¢Á¾ ¿ë±â-±â±¸-Æ÷Àå µî¿¡¼ ¿ëÃâµÇ´Â µ¶¼º¹°ÁúÀÌ ¹®Á¦°¡ µÈ´Ù. |
||
| ¿µ¹® | carbon monoxide poisoning | ÇÑ±Û | ÀÏ»êÈź¼ÒÁßµ¶ |
|---|---|---|---|
| ¼³¸í | ÀÏ»êÈź¼ÒÀÇ ÈíÀÔ¿¡ ÀÇÇÏ¿© »êÈÇì¸ð±Û·ÎºóÀÌ Ä«¸£º¹½ÃÇì¸ð±Û·ÎºóÀ¸·Î º¯ÈÇÔÀ¸·Î½á ÀϾ´Â Áßµ¶. ÁßÃ߽Űæ°èÀå¾Ö¸¦ ÀÏÀ¸Å°°í Á×À½¿¡ À̸£±â°í ÇÑ´Ù. ÀÏ»êÈź¼Ò´Â ź¼Ò¸¦ ÇÔÀ¯ÇÑ À¯±â¹°ÀÌ ºÒ¿ÏÀü¿¬¼ÒÇÒ ¶§ ¹ß»ýÇÑ´Ù. µû¶ó¼ Á¦Ã¶, µµ½Ã°¡½º Á¦Á¶, °¡Á¤¿¡¼ ¹ß»ýÇϸç ÀÚµ¿Â÷ ¹è±â°¡½º¿¡µµ Æ÷ÇԵǾî ÀÖ°í °¡Á¤¿¡¼ ¿¬·áÀÇ ¿¬¼Ò¿¡ ÀÇÇØ¼µµ »ý±ä´Ù. ÀÏ»êÈź¼Ò¸¦ ÈíÀÔÇÏ¸é Æó¿¡¼ Ç÷¾×¼ÓÀÇ Ç÷»ö¼Ò¿Í °áÇÕÇÏ¿© ÀÏ»êÈź¼ÒÇì¸ð±Û·ÎºóÀ» Çü¼ºÇϰí, ÀÌ ¶§¹®¿¡ Ç÷¾×ÀÇ »ê¼Ò¿î¹Ý´É·ÂÀÌ »ó½ÇµÇ¾î ³»ºÎÀûÀÎ Áú½Ä»óÅ¿¡ ºüÁö°Ô µÈ´Ù. ÀÏ»êÈź¼Ò¿Í Çì¸ð±Û·Îºó°úÀÇ Ä£È¼ºÀº ±ØÈ÷ °ÇÏ¿© »ê¼Òº¸´Ù 250¹èÀÇ ¼¼±â·Î °áÇÕÇÑ´Ù. »ç¶÷¿¡ µû¶ó ÀÏ»êÈź¼Ò¿¡ ´ëÇÑ °¨¼ö¼ºÀÌ ´Ù¸£Áö¸¸, °ø±â ¼Ó¿¡ 0.001%¸¸ µé¾îÀ־ Áßµ¶À» ÀÏÀ¸Å²´Ù. ¶Ç 0.06%¿¡¼´Â 1½Ã°£¸¸ ÈíÀÔÇÏ¸é µÎÅëÀ» ÀÏÀ¸Å°°í 2½Ã°£ÀÌ¸é ½Ç½ÅÇÑ´Ù. ¶Ç 0.1%À» °æ¿ì´Â 1½Ã°£ À̳»¿¡ ½Ç½ÅÇϰí 4½Ã°£ÀÌ¸é »ç¸ÁÇÑ´Ù. Áßµ¶ Áõ¼¼´Â Á¶Á÷ÀÇ ¹«»ê¼ÒÁõ¿¡ ÀÇÇÑ °ÍÀ¸·Î¼, ±Þ¼ºÁßµ¶Àº ±Þ°ÝÈ÷ »ç¸ÁÇÏ´Â ¼öµµ ÀÖÁö¸¸, ´ë°³´Â óÀ½¿¡ µÎÅë-Çö±âÁõ-±Í¿ï¸²-±¸¿ª-±¸Åä µîÀÌ ÀÖ°í, »çÁöÀÇ ¿îµ¿ÀÌ ºÒ°¡´ÉÇÏ°Ô µÇ¸ç, ´Ù¼ÒÀÇ ÀǽÄÀÌ ³²¾Æ À־ ±×´ë·Î Á×À½¿¡ À̸£°Ô µÈ´Ù. Ÿ°¢ÀûÀ¸·Î´Â ¾ó±¼¿¡ È«Á¶¸¦ ¶ì°í Àü½Å¿¡ ¹«´Ì ¸ð¾çÀÇ ¹ßÀûÀÌ ³ªÅ¸³ª¸ç, È£ÈíÀÌ °¡´Ã°í ºÒ±ÔÄ¢ÇÏ°Ô µÈ´Ù. ÄÚ¸¦ °ñ°í ü¿ÂÀÌ ³»·Á°¡°í Àü½ÅÀÇ ±ÙÀ° À̿ µîÀÌ º¸À̸ç, È£Èí°ï¶õÀÇ Áõ¼¼°¡ º¸ÀÌÁö ¾Ê´Â Áß¿¡ È£ÈíÀÌ Á¤ÁöÇÏ°Ô µÈ´Ù. |
||
| ¿µ¹® | staphylococcal food poisoning | ÇÑ±Û | Æ÷µµ¾Ë±Õ ½ÄÁßµ¶ |
|---|---|---|---|
| ¼³¸í | Å©¸²ÀÌ µé¾î ÀÖ´Â °úÀÚ, Ä¿½ºÅ¸µå(custards), Ä¡Áî¿Í °°Àº ½ÄǰÀ̳ª, À°·ù¿¡ Ȳ»ö Æ÷µµ¾Ë±ÕÀÌ »ý¼ºÇϴ âÀÚ°üµ¶ÀÌ ÇÔÀ¯µÈ °ÍÀ» ¼·ÃëÇÏ¿© ÀϾ´Â ½ÄÁßµ¶À¸·Î¼ °©ÀÛ½º·¯¿î ¹ßº´, µÎÅë, ħºÐºñ, ±¸¿ª, ±¸Åä, ¼³»ç, º¹ºÎ»êÅë ¹× ¶¡³²À» Ư¡À¸·Î Çϸç, ¹ßÀÛ ÈÄ 5~6½Ã°£ Áö¼ÓÇÑ´Ù. |
||
| CVS | cardiovascular surgery; cardiovascular system; challenge virus strain; chorionic villi sampling; cle... |
|---|---|
| ACVD | acute cardiovascular disease, atherosclerotic cardiovascular disease |
| ASCVD | arteriosclerotic cardiovascular disease; atherosclerotic cardiovascular disease |
| CVI | cardiovascular incident; cardiovascular insufficiency; cerebrovascular incident; cerebrovascular ins... |
| CVR | cardiovascular-renal; cardiovascular-respiratory; cephalic vasomotor response; cerebrovascular resis... |
| DSP | Diarrhetic Shellfish Poisoning |
|---|---|
| PSP | Paralytic Shellfish Poisoning |
| CVS | Cardiovascular system |
| CWA | Chemical warfare agents |
| DBA | Dentin bonding agents |
| cardiovascular agents | Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (12 Dec 1998) |
|---|---|
| cardiovascular system | The heart and the blood vessels by which blood is pumped and circulated through the body. (12 Dec 1998) |
| anti-allergic and respiratory system agents | A collective term for drugs used to treat allergic reactions as well as those drugs that produce an effect on the respiratory system. (12 Dec 1998) |
| central nervous system agents | A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "non-specific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with non-specific mechanisms are generally further classed according to whether they produce behavioural depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (12 Dec 1998) |
| respiratory system agents | Drugs used for their effects on the respiratory system. (12 Dec 1998) |
| peripheral nervous system agents | Drugs that act principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system. (12 Dec 1998) |
| sensory system agents | Drugs that act on neuronal sensory receptors resulting in an increase, decrease, or modification of afferent nerve activity. (12 Dec 1998) |
| cardiovascular | <cardiology, physiology> Pertaining to the heart and blood vessels. (18 Nov 1997) |
| cardiovascular abnormalities | Congenital structural abnormalities of the cardiovascular system. (12 Dec 1998) |
| cardiovascular deconditioning | A change in cardiovascular function, especially after periods of actual or simulated weightlessness or diminished power or strength, probably related to the shift of a quantity of blood from the lower limbs to the thorax, resulting in reflex diuresis and a reduction of blood volume. (12 Dec 1998) |
| cardiovascular physiology | Functions and activities of the cardiovascular system as a whole or of any of its parts. (12 Dec 1998) |
| cardiovascular radiology | The clinical subspecialty of radiology concerned with diagnosis and treatment of diseases of the vascular system. (05 Mar 2000) |
| cardiovascular surgery | The use of surgery to fix disorders of the heartand/or blood vessels. (09 Oct 1997) |
| cardiovascular surgical procedures | Surgery performed on the heart or blood vessels. (12 Dec 1998) |
| cardiovascular syphilis | Involvement of the cardiovascular system seen in late syphilis, usually resulting in aortitis, aneurysm formation, and aortic valvular insufficiency. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|